Oil prices recovered modestly on Tuesday after Brent crude and WTI fell more than 2% in the previous session. Brent futures rose 27 cents, or 0.3%, to $92.44 a barrel by 0330 GMT. U.S. West Texas Intermediate gained 37 cents, or 0.4%, to $85.38. The rebound followed Monday’s sharp pullback, which ended six consecutive sessions of gains across the two benchmark crude contracts.

    News

    Nearly 22,000 Pakistanis deported from Gulf over four months for visa violations and begging highlights tightening immigration enforcement across the Middle East. The written statement submitted by the Ministry for Narcotics Control detailed that Saudi Arabia accounted for the vast majority of repatriations, expelling 15,500 Pakistani nationals during the four-month window. The United Arab Emirates deported 3,803 individuals, followed by Oman with 1,606 deportations, Bahrain with 521, Qatar with 429, and Kuwait with 97. A significant subset of the repatriated individuals involved 4,628 absconders, 1,294 individuals who served prison sentences, and 472 individuals specifically identified as beggars.

    Health

    The European Commission has expanded its Ebola response with a €2.1 million purchase of PCR tests for the Bundibugyo virus outbreak. The agreement covers open-platform tests that laboratories can use with existing systems. Shipments are due to start in August as health teams confront a large outbreak centered in the Democratic Republic of the Congo and affecting parts of the wider region.

    Australian researchers from Adelaide University and the Olivia Newton-John Cancer Research Institute have identified a novel molecular switch that drives the spread of aggressive tumors. Published in EMBO Molecular Medicine, the breakthrough study reveals that Australian researchers uncover a promising new way to tackle triple-negative breast cancer by restoring a critical regulatory molecule known as miR-342. The discovery opens new avenues to prevent life-threatening secondary cancers in organs such as the lungs and bones.

    The Democratic Republic of the Congo will receive 70,000 Ervebo Ebola vaccine doses as the Bundibugyo outbreak expands. Congolese authorities reported 5,208 confirmed cases and 2,476 deaths as of Aug. 18. The outbreak now affects 56 health zones across six provinces in the east and northeast. Authorities also listed 1,115 recoveries, while 730 patients remained in isolation or hospital care. The International Coordinating Group on Vaccine Provision approved the release after the government requested doses from the global Ebola stockpile. WHO said 20,000 doses will support a Phase 3 clinical trial focused on Bundibugyo virus disease. The other 50,000 doses will go to frontline and health workers under current vaccination recommendations. WHO and Africa CDC welcomed the allocation, which officials announced on Aug. 20.

    Automotive

    German luxury sports car manufacturer Porsche announced an agreement with labor representatives on Monday to reduce its workforce by an additional 5,000 positions by 2035 as part of a restructuring program. The decision brings total planned job eliminations across the company to approximately 9,000 positions, representing roughly 21 percent of its 42,066 workforce. Company leadership confirmed that Porsche to cut 5,000 more jobs under restructuring plan negotiations following months of talks between management and labor councils. The initiative aims to bolster operational efficiency as the vehicle producer confronts declining market share in Asia, elevated global tariffs, and sluggish demand for electric vehicles.

    Entertainment

    Lifestyle